IT1211095B - USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS. - Google Patents

USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS.

Info

Publication number
IT1211095B
IT1211095B IT8123543A IT2354381A IT1211095B IT 1211095 B IT1211095 B IT 1211095B IT 8123543 A IT8123543 A IT 8123543A IT 2354381 A IT2354381 A IT 2354381A IT 1211095 B IT1211095 B IT 1211095B
Authority
IT
Italy
Prior art keywords
trazodone
treatment
gastroduodenal ulcers
gastroduodenal
ulcers
Prior art date
Application number
IT8123543A
Other languages
Italian (it)
Other versions
IT8123543A0 (en
Inventor
Bruno Silvestrini
Original Assignee
Roma Aziende Chimiche Riunite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roma Aziende Chimiche Riunite filed Critical Roma Aziende Chimiche Riunite
Priority to IT8123543A priority Critical patent/IT1211095B/en
Publication of IT8123543A0 publication Critical patent/IT8123543A0/en
Priority to BE0/208811A priority patent/BE894110A/en
Priority to AU87157/82A priority patent/AU537645B2/en
Priority to JP57142564A priority patent/JPS5839623A/en
Application granted granted Critical
Publication of IT1211095B publication Critical patent/IT1211095B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT8123543A 1981-08-17 1981-08-17 USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS. IT1211095B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT8123543A IT1211095B (en) 1981-08-17 1981-08-17 USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS.
BE0/208811A BE894110A (en) 1981-08-17 1982-08-13 USE OF TRAZODONE IN THE TREATMENT OF GASTROINTESTINAL ULCERS
AU87157/82A AU537645B2 (en) 1981-08-17 1982-08-13 Trazodone for ulcers
JP57142564A JPS5839623A (en) 1981-08-17 1982-08-16 Antiulcer containing trazodone as essential component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8123543A IT1211095B (en) 1981-08-17 1981-08-17 USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS.

Publications (2)

Publication Number Publication Date
IT8123543A0 IT8123543A0 (en) 1981-08-17
IT1211095B true IT1211095B (en) 1989-09-29

Family

ID=11207995

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8123543A IT1211095B (en) 1981-08-17 1981-08-17 USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS.

Country Status (4)

Country Link
JP (1) JPS5839623A (en)
AU (1) AU537645B2 (en)
BE (1) BE894110A (en)
IT (1) IT1211095B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071603A1 (en) * 2007-08-03 2009-02-04 Acraf TRAZODONE AND CHLORIDATED TRAZODONE IN PURIFIED FORM

Also Published As

Publication number Publication date
AU8715782A (en) 1983-02-24
BE894110A (en) 1982-12-01
JPH0235722B2 (en) 1990-08-13
IT8123543A0 (en) 1981-08-17
JPS5839623A (en) 1983-03-08
AU537645B2 (en) 1984-07-05

Similar Documents

Publication Publication Date Title
IT8222347A0 (en) BLOOD PURIFICATION DEVICE.
IT8467201A1 (en) RECTAL INSERT FOR THE TREATMENT OF HEMORROIDS.
NL7708841A (en) WASTE WATER TREATMENT.
DK162074C (en) fluid treatment apparatus
NL7805838A (en) SURFACE TREATMENT.
SE7810758L (en) WASTEWATER TREATMENT
ES269846Y (en) PROVISION OF TREATMENT OF PESTANES.
IT8024806A0 (en) BLOOD OXYGENATOR.
IT8149790A0 (en) CATARACT TREATMENT
NL7704095A (en) WASTE WATER TREATMENT.
IT8025806A0 (en) BLOOD OXYGENATOR.
DK207176A (en) 1,2,2,2-TETRAFLUOROTHEHYL-FLUORMETHYLETHER, ITS MANUFACTURE AND USE
DK487781A (en) DENTAL TREATMENT PLACE
AR219788A1 (en) SEWAGE TREATMENT PROCEDURE
IT1156373B (en) COMPOSITION FOR GLAUCOMA TREATMENT
DK485981A (en) SURFACE TREATMENT
FI792926A7 (en) High-performance wastewater treatment system.
IT1211095B (en) USE OF TRAZODONE IN THE TREATMENT OF GASTRODUODENAL ULCERS.
ES505311A0 (en) PROCEDURE FOR PREPARING NEW CYTHOSTATIC COMPOUNDS OF THE TYPE OF RHYLLASTINES AND THE LIKE.
IT8123881A0 (en) HEAT TREATMENT.
IT1192960B (en) PREPARED FOR THE TREATMENT OF L ACNE
IT7819623A0 (en) COMPOSITION SUITABLE FOR THE PURIFICATION OF BLOOD AND ITS USES.
FI831473A7 (en) Pulp treatment with oxygen.
FI820342A7 (en) Treating inflammation.
NO811814L (en) WASTE TREATMENT.